Oncological and functional outcomes of transoral surgery for the treatment of oropharyngeal cancer

[1]  Amy Y. Chen,et al.  Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009 , 2014, The Laryngoscope.

[2]  G. Calais,et al.  Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Khuri,et al.  Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. , 2013, The Lancet. Oncology.

[4]  H. Christiansen,et al.  Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma , 2013, European Archives of Oto-Rhino-Laryngology.

[5]  R. Tishler,et al.  Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  G. Weinstein,et al.  Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. , 2012, Archives of otolaryngology--head & neck surgery.

[7]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[8]  R. Hayden,et al.  Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study , 2011, Head & neck.

[9]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Tishler,et al.  Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. , 2011, The Lancet. Oncology.

[11]  G. Weinstein,et al.  Transoral robotic surgery for advanced oropharyngeal carcinoma. , 2010, Archives of otolaryngology--head & neck surgery.

[12]  William C. Perry,et al.  Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. , 2009, Archives of otolaryngology--head & neck surgery.

[13]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  K. Olsen,et al.  Transoral resection of tonsillar squamous cell carcinoma , 2009, The Laryngoscope.

[15]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Garden,et al.  Factors Associated with Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis , 2008 .

[17]  T. Gorlia,et al.  Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.

[18]  A. Markoe,et al.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. , 2007, The New England journal of medicine.

[19]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[20]  D. Lindquist,et al.  The incidence of tonsillar cancer in Sweden is increasing , 2007, Acta oto-laryngologica.

[21]  O. Laccourreye,et al.  Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. , 2005, Archives of otolaryngology--head & neck surgery.

[22]  D. Brasnu,et al.  Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. , 2005, Archives of otolaryngology--head & neck surgery.

[23]  G. Calais,et al.  Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[25]  Fabrice Denis,et al.  Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. , 2003, International journal of radiation oncology, biology, physics.

[26]  S. Stringer,et al.  Squamous cell carcinoma of the oropharynx , 2002, Cancer.

[27]  G. Calais,et al.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.

[28]  T. Wendt,et al.  Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.